{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:48:43Z","timestamp":1783432123179,"version":"3.54.6"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,20]]},"DOI":"10.7759\/cureus.97351","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T18:36:03Z","timestamp":1763663763000},"source":"Crossref","is-referenced-by-count":2,"title":["Type 2 Diabetes in Obese Individuals Is Associated With Central Adiposity and Atherogenic Dyslipidemia but Does Not Exacerbate Systemic Inflammation: A Cross-Sectional Study"],"prefix":"10.7759","author":[{"given":"Onur","family":"Gursoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enis","family":"Akca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Oktay","family":"Tarhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metin","family":"Ozgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demet","family":"Yalcin Kehribar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)00355-1","article-title":"Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021","volume":"405","year":"2025","unstructured":"Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050. a forecasting study for the Global Burden of Disease Study 2021. Lancet. 2025, 405:813-38. 10.1016\/S0140-6736(25)00355-1","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-21061-z","article-title":"Prevalence of complications and comorbidities associated with obesity: a health insurance claims analysis","volume":"25","author":"Bae JP","year":"2025","unstructured":"Bae JP, Nelson DR, Boye KS, Mather KJ. Prevalence of complications and comorbidities associated with obesity: a health insurance claims analysis. BMC Public Health. 2025, 25:273. 10.1186\/s12889-024-21061-z","journal-title":"BMC Public Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1198984","article-title":"Effects of multi-organ crosstalk on the physiology and pathology of adipose tissue","volume":"14","author":"Wang S","year":"2023","unstructured":"Wang S, Liu Y, Chen J, He Y, Ma W, Liu X, Sun X. Effects of multi-organ crosstalk on the physiology and pathology of adipose tissue. Front Endocrinol (Lausanne). 2023, 14:1198984. 10.3389\/fendo.2023.1198984","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13956","article-title":"Is adipose tissue inflammation the culprit of obesity-associated comorbidities?","volume":"26","author":"Turner L","year":"2025","unstructured":"Turner L, Wanasinghe AI, Brunori P, Santosa S. Is adipose tissue inflammation the culprit of obesity-associated comorbidities?. Obes Rev. 2025, 26:e13956. 10.1111\/obr.13956","journal-title":"Obes Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14010072","article-title":"Oxidative stress and cardiovascular complications in type 2 diabetes: from pathophysiology to lifestyle modifications","volume":"14","author":"Caturano A","year":"2025","unstructured":"Caturano A, Rocco M, Tagliaferri G, et al.. Oxidative stress and cardiovascular complications in type 2 diabetes: from pathophysiology to lifestyle modifications. Antioxidants (Basel). 2025, 14:10.3390\/antiox14010072","journal-title":"Antioxidants (Basel)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-22848-z","article-title":"Comparison of adiposity anthropometric indices and their associations with visceral fat levels determined by bioelectrical impedance analysis among diabetic patients","volume":"12","author":"Tuglo LS","year":"2022","unstructured":"Tuglo LS. Comparison of adiposity anthropometric indices and their associations with visceral fat levels determined by bioelectrical impedance analysis among diabetic patients. Sci Rep. 2022, 12:17824. 10.1038\/s41598-022-22848-z","journal-title":"Sci Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1205687","article-title":"Associations of complete blood cell count-derived inflammatory biomarkers with asthma and mortality in adults: a population-based study","volume":"14","author":"Ke J","year":"2023","unstructured":"Ke J, Qiu F, Fan W, Wei S. Associations of complete blood cell count-derived inflammatory biomarkers with asthma and mortality in adults: a population-based study. Front Immunol. 2023, 14:1205687. 10.3389\/fimmu.2023.1205687","journal-title":"Front Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.316101","article-title":"Obesity phenotypes, diabetes, and cardiovascular diseases","volume":"126","author":"Pich\u00e9 ME","year":"2020","unstructured":"Pich\u00e9 ME, Tchernof A, Despr\u00e9s JP. Obesity phenotypes, diabetes, and cardiovascular diseases. Circ Res. 2020, 126:1477-500. 10.1161\/CIRCRESAHA.120.316101","journal-title":"Circ Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.34836","article-title":"Surrogate adiposity markers and mortality","volume":"6","author":"Khan I","year":"2023","unstructured":"Khan I, Chong M, Le A, et al.. Surrogate adiposity markers and mortality. JAMA Netw Open. 2023, 6:e2334836. 10.1001\/jamanetworkopen.2023.34836","journal-title":"JAMA Netw Open"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(19)30084-1","article-title":"Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement","volume":"7","author":"Neeland IJ","year":"2019","unstructured":"Neeland IJ, Ross R, Despr\u00e9s JP, et al.. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019, 7:715-25. 10.1016\/S2213-8587(19)30084-1","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00033.2011","article-title":"Pathophysiology of human visceral obesity: an update","volume":"93","author":"Tchernof A","year":"2013","unstructured":"Tchernof A, Despr\u00e9s JP. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013, 93:359-404. 10.1152\/physrev.00033.2011","journal-title":"Physiol Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.01.039","article-title":"New insights into the pathophysiology of dyslipidemia in type 2 diabetes","volume":"239","author":"Taskinen MR","year":"2015","unstructured":"Taskinen MR, Bor\u00e9n J. New insights into the pathophysiology of dyslipidemia in type 2 diabetes. Atherosclerosis. 2015, 239:483-95. 10.1016\/j.atherosclerosis.2015.01.039","journal-title":"Atherosclerosis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2013.10.015","article-title":"The nuances of atherogenic dyslipidemia in diabetes: focus on triglycerides and current management strategies","volume":"65","author":"Manoria PC","year":"2013","unstructured":"Manoria PC, Chopra HK, Parashar SK, Dutta AL, Pinto B, Mullasari A, Prajapati S. The nuances of atherogenic dyslipidemia in diabetes: focus on triglycerides and current management strategies. Indian Heart J. 2013, 65:683-90. 10.1016\/j.ihj.2013.10.015","journal-title":"Indian Heart J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-021-01612-8","article-title":"Triglyceride\/low-density-lipoprotein cholesterol ratio is the most valuable predictor for increased small, dense LDL in type 2 diabetes patients","volume":"21","author":"Ouchi G","year":"2022","unstructured":"Ouchi G, Komiya I, Taira S, Wakugami T, Ohya Y. Triglyceride\/low-density-lipoprotein cholesterol ratio is the most valuable predictor for increased small, dense LDL in type 2 diabetes patients. Lipids Health Dis. 2022, 21:4. 10.1186\/s12944-021-01612-8","journal-title":"Lipids Health Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2462447","article-title":"Waist-to-hip ratio better reflect beta-cell function and predicts diabetes risk in adult with overweight or obesity","volume":"57","author":"Liu N","year":"2025","unstructured":"Liu N, Wang B, Zhang G, et al.. Waist-to-hip ratio better reflect beta-cell function and predicts diabetes risk in adult with overweight or obesity. Ann Med. 2025, 57:2462447. 10.1080\/07853890.2025.2462447","journal-title":"Ann Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2009.286","article-title":"Gluteofemoral body fat as a determinant of metabolic health","volume":"34","author":"Manolopoulos KN","year":"2010","unstructured":"Manolopoulos KN, Karpe F, Frayn KN. Gluteofemoral body fat as a determinant of metabolic health. Int J Obes (Lond). 2010, 34:949-59. 10.1038\/ijo.2009.286","journal-title":"Int J Obes (Lond)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2009.12.006","article-title":"Adipose tissue expandability, lipotoxicity and the metabolic syndrome--an allostatic perspective","volume":"1801","author":"Virtue S","year":"2010","unstructured":"Virtue S, Vidal-Puig A. Adipose tissue expandability, lipotoxicity and the metabolic syndrome--an allostatic perspective. Biochim Biophys Acta. 2010, 1801:338-49. 10.1016\/j.bbalip.2009.12.006","journal-title":"Biochim Biophys Acta"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-013-9746-4","article-title":"Increased concentration of C-reactive protein in obese patients with type 2 diabetes is associated with obesity and presence of diabetes but not with macrovascular and microvascular complications or glycemic control","volume":"37","author":"Fronczyk A","year":"2014","unstructured":"Fronczyk A, Mol\u0119da P, Safranow K, Piechota W, Majkowska L. Increased concentration of C-reactive protein in obese patients with type 2 diabetes is associated with obesity and presence of diabetes but not with macrovascular and microvascular complications or glycemic control. Inflammation. 2014, 37:349-57. 10.1007\/s10753-013-9746-4","journal-title":"Inflammation"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0176","article-title":"Neutrophil:lymphocyte ratio is positively related to type 2 diabetes in a large-scale adult population: a Tianjin Chronic Low-Grade Systemic Inflammation and Health cohort study","volume":"173","author":"Guo X","year":"2015","unstructured":"Guo X, Zhang S, Zhang Q, et al.. Neutrophil:lymphocyte ratio is positively related to type 2 diabetes in a large-scale adult population: a Tianjin Chronic Low-Grade Systemic Inflammation and Health cohort study. Eur J Endocrinol. 2015, 173:217-25. 10.1530\/EJE-15-0176","journal-title":"Eur J Endocrinol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1245199","article-title":"Association between systemic immune-inflammation index and diabetes: a population-based study from the NHANES","volume":"14","author":"Nie Y","year":"2023","unstructured":"Nie Y, Zhou H, Wang J, Kan H. Association between systemic immune-inflammation index and diabetes: a population-based study from the NHANES. Front Endocrinol (Lausanne). 2023, 14:1245199. 10.3389\/fendo.2023.1245199","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-024-02240-8","article-title":"Association between obesity and systemic immune inflammation index, systemic inflammation response index among US adults: a population-based analysis","volume":"23","author":"Zhou Y","year":"2024","unstructured":"Zhou Y, Wang Y, Wu T, Zhang A, Li Y. Association between obesity and systemic immune inflammation index, systemic inflammation response index among US adults: a population-based analysis. Lipids Health Dis. 2024, 23:245. 10.1186\/s12944-024-02240-8","journal-title":"Lipids Health Dis"},{"key":"ref22","article-title":"How obesity affects the neutrophil\/lymphocyte and platelet\/lymphocyte ratio, systemic immune-inflammatory index and platelet indices: a retrospective study","volume":"20","author":"Furuncuo\u011flu Y","year":"2016","unstructured":"Furuncuo\u011flu Y, Tulgar S, Dogan AN, Cakar S, Tulgar YK, Cakiroglu B. How obesity affects the neutrophil\/lymphocyte and platelet\/lymphocyte ratio, systemic immune-inflammatory index and platelet indices: a retrospective study. Eur Rev Med Pharmacol Sci. 2016, 20:1300-6.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1177\/1060028020985303","article-title":"Effect of metformin on circulating levels of inflammatory markers in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"55","author":"Karbalaee-Hasani A","year":"2021","unstructured":"Karbalaee-Hasani A, Khadive T, Eskandari M, et al.. Effect of metformin on circulating levels of inflammatory markers in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Ann Pharmacother. 2021, 55:1096-109. 10.1177\/1060028020985303","journal-title":"Ann Pharmacother"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12075","article-title":"Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK\/NF-\u03baB activation","volume":"12","author":"Moiseeva O","year":"2013","unstructured":"Moiseeva O, Desch\u00eanes-Simard X, St-Germain E, et al.. Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK\/NF-\u03baB activation. Aging Cell. 2013, 12:489-98. 10.1111\/acel.12075","journal-title":"Aging Cell"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker PM","year":"2008","unstructured":"Ridker PM, Danielson E, Fonseca FA, et al.. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008, 359:2195-207. 10.1056\/NEJMoa0807646","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.10.2486","article-title":"Serum ferritin is associated with visceral fat area and subcutaneous fat area","volume":"28","author":"Iwasaki T","year":"2005","unstructured":"Iwasaki T, Nakajima A, Yoneda M, et al.. Serum ferritin is associated with visceral fat area and subcutaneous fat area. Diabetes Care. 2005, 28:2486-91. 10.2337\/diacare.28.10.2486","journal-title":"Diabetes Care"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-022-03198-3","article-title":"Serum ferritin levels are associated with adipose tissue dysfunction-related indices in obese adults","volume":"201","author":"Ding X","year":"2023","unstructured":"Ding X, Bian N, Wang J, Chang X, An Y, Wang G, Liu J. Serum ferritin levels are associated with adipose tissue dysfunction-related indices in obese adults. Biol Trace Elem Res. 2023, 201:636-43. 10.1007\/s12011-022-03198-3","journal-title":"Biol Trace Elem Res"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25092224","article-title":"Anti-inflammatory strategies targeting metaflammation in type 2 diabetes","volume":"25","author":"Kury\u0142owicz A","year":"2020","unstructured":"Kury\u0142owicz A, Ko\u017aniewski K. Anti-inflammatory strategies targeting metaflammation in type 2 diabetes. Molecules. 2020, 25:10.3390\/molecules25092224","journal-title":"Molecules"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-1856","article-title":"Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes","volume":"32","author":"Sam S","year":"2009","unstructured":"Sam S, Haffner S, Davidson MH, et al.. Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes. Diabetes Care. 2009, 32:932-7. 10.2337\/dc08-1856","journal-title":"Diabetes Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/428116-type-2-diabetes-in-obese-individuals-is-associated-with-central-adiposity-and-atherogenic-dyslipidemia-but-does-not-exacerbate-systemic-inflammation-a-cross-sectional-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T18:36:04Z","timestamp":1763663764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/428116-type-2-diabetes-in-obese-individuals-is-associated-with-central-adiposity-and-atherogenic-dyslipidemia-but-does-not-exacerbate-systemic-inflammation-a-cross-sectional-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.97351","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,20]]}}}